Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...

Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie

Insights into mCRPC in China, Thailand and Indonesia - expert discussion ( Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie )

PSA as a marker of disease in patients with prostate cancer and bone metastases

Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal

PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

MET variant as a prognostic marker in clear cell renal cell carcinoma

Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA

MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )

Gleason score efficacy predictions in abiraterone acetate therapy with mCRPC

Dr Karim Fizazi - Institut Gustave Roussy, Paris, France

Gleason score efficacy predictions in abiraterone acetate therapy with mCRPC ( Dr Karim Fizazi - Institut Gustave Roussy, Paris, France )

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )

Understanding the biology of the disease to guide treatment choices

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland

Understanding the biology of the disease to guide treatment choices ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland )

Drop in breast cancer mortality in developed countries varies

Dr Donald Berry - MD Anderson Cancer Center, Houston, USA

Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )

Hypoxic metabolism in breast cancer: how to overcome resistance to anti...

Prof Adrian Harris - University of Oxford, Oxford, UK

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert...

Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )

More from ecancer